chr3-46370444-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NR_125406.1(CCR5AS):n.565+800T>C variant causes a intron, non coding transcript change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.491 in 151,794 control chromosomes in the GnomAD database, including 18,573 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity,protective (no stars).
Frequency
Genomes: 𝑓 0.49 ( 18573 hom., cov: 30)
Consequence
CCR5AS
NR_125406.1 intron, non_coding_transcript
NR_125406.1 intron, non_coding_transcript
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.587
Genes affected
CCR5AS (HGNC:54398): (CCR5 antisense RNA)
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.593 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCR5AS | NR_125406.1 | n.565+800T>C | intron_variant, non_coding_transcript_variant | |||||
CCR5 | NM_000579.4 | c.-301+246A>G | intron_variant | NP_000570.1 | ||||
CCR5 | NM_001100168.2 | c.-66+246A>G | intron_variant | NP_001093638.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCR5AS | ENST00000701879.1 | n.347+800T>C | intron_variant, non_coding_transcript_variant | |||||||
CCR5AS | ENST00000451485.2 | n.565+800T>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.491 AC: 74529AN: 151674Hom.: 18552 Cov.: 30
GnomAD3 genomes
AF:
AC:
74529
AN:
151674
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.491 AC: 74586AN: 151794Hom.: 18573 Cov.: 30 AF XY: 0.496 AC XY: 36779AN XY: 74166
GnomAD4 genome
AF:
AC:
74586
AN:
151794
Hom.:
Cov.:
30
AF XY:
AC XY:
36779
AN XY:
74166
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1859
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity; protective
Submissions summary: Pathogenic:1Benign:3
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Acquired immunodeficiency syndrome, delayed progression to Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2003 | - - |
CCR5-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 18, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Susceptibility to HIV infection Benign:1
protective, no assertion criteria provided | literature only | OMIM | Jul 08, 2003 | - - |
CCR5 PROMOTER POLYMORPHISM Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Jul 08, 2003 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at